GlaxoSmithKline | GSK - Ebit

Stock Price
2,194.00
Daily Change
-19.00 -0.86%
Monthly
19.99%
Yearly
51.05%
Q1 Forecast
2,168.74

GlaxoSmithKline reported GBP1.44B in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
AbbVie USD 5.81B 4.36B Dec/2025
Alcon AG USD 334M 84M Sep/2025
Almirall EUR 43.02M 28.78M Jun/2025
Amgen USD 3.96B 464M Dec/2025
argenx SE USD 349.97M 61.94M Sep/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Bayer EUR -399M 363M Sep/2025
Biogen USD 659.6M 157M Sep/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
Fresenius EUR 574M 14M Sep/2025
Fresenius Medical Care EUR 449.94M 18.94M Sep/2025
Galapagos EUR -41.67M 15.35M Sep/2025
Genmab DKK 432M 900.27M Jun/2025
Gilead Sciences USD 2.96B 551M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Glaxosmithkline GBP 3.76B 1.69B Sep/2025
GRIFOLS EUR 352.11M 20.18M Sep/2025
Hikma Pharmaceutical USD 317M 85M Dec/2024
Lonza CHF 673M 54M Jun/2025
Merck EUR 1.21B 180M Sep/2025
Merck USD 6.24B 1.32B Dec/2025
Novartis USD -9.19B 13.87B Jun/2025
Novo Nordisk DKK 32.38B 1.7B Dec/2025
Orion EUR 328.1M 207.1M Dec/2025
Pfizer USD 4.65B 71M Dec/2025
Philips EUR 719M 390M Dec/2025
Recordati EUR 165.64M 21.71M Sep/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Smith & Nephew USD 440M 50M Dec/2025
UCB EUR 502M 168M Dec/2024